Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

22.36 -0.48 (-2.10%)
Official Closing Price Updated: 4:10 PM EDT, Jul 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Don’t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.
Dividend stocks have proven themselves over time to outperform non-paying stocks so it's smart to buy them when they go on sale. 
Via InvestorPlace
A Bull Market Is Coming: 3 Top Dividend Stocks to Buy Now
These steadfast investments can help you earn more passive income. 
Via The Motley Fool
Looking At Kenvue's Recent Unusual Options Activity
 
Via Benzinga
3 Things About Johnson & Johnson That Smart Investors Know
J&J shares have missed out on the market rally so far this year. 
Via The Motley Fool
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation - KVUE
WHY: NEW YORK, NY - (NewMediaWire) - September 25, 2023 - Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of... 
Via TheNewswire.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Check Out What Whales Are Doing With KVUE
 
Via Benzinga
Looking Into Kenvue's Recent Short Interest
 
Via Benzinga
3 Best Stocks to Buy in September and Hold Forever
Healthcare blue chip stocks with proven track records can be excellent long-term investments. 
Via The Motley Fool
3 Reasons SharkNinja Is Swimming Toward New Highs
Shares of SharkNinja, Inc. are up more than 50% since August 4th — and becoming a popular momentum bet amongst retail traders. 
Via MarketBeat
Kenvue to Announce Third Quarter 2023 Results on October 26, 2023
From Kenvue Inc.
Via Business Wire
KVUE INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation – KVUE
From Rosen Law Firm
Via Business Wire
Kenvue Unusual Options Activity For September 13
 
Via Benzinga
Better Buy: J&J vs. Kenvue
You can count on both of these companies for passive income, too. 
Via The Motley Fool
Analyst Ratings for Kenvue
 
Via Benzinga
Kenvue Unusual Options Activity
 
Via Benzinga
2 Incredibly Cheap Dividend Stocks to Buy Now
High-quality dividend stocks are rarely cheap. These two names are an exception. 
Via The Motley Fool
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
Discover how these seven standout companies offer both security and growth potential in an uncertain financial landscape. 
Via InvestorPlace
3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income
These companies generate durable and growing cash flows. 
Via The Motley Fool
Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc. (NYSE: PATH) is a "decent" stock. Cramer said the company is not making money, and he doesn’t recommend stocks that don’t make money. 
Via Benzinga
3 Great Dividend Stocks You Can Buy for Less Than $50
These steady-Eddie operators are perfect bedrock stocks for investors despite trading for less than $50. 
Via The Motley Fool
3 Blue-Chip Stocks to Watch in the ‘Green Zone’
Now may be the time to take a look at these three blue-chips, as each one is currently in the "Green Zone stocks" category. 
Via InvestorPlace
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 11, 2023
 
Via Benzinga
Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip
The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business. 
Via The Motley Fool
Topics Stocks
The 7 Best Dow Stocks to Buy Now: September 2023
These are the best Dow stocks to buy because they offer long-term growth, a margin of safety and reliability in an otherwise volatile market. 
Via InvestorPlace
Topics Stocks
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
 
Via Benzinga
J&J Spinoff Kenvue is the New Dividend Aristocrat on the Block
Newly public company Kenvue, a spinoff from Johnson & Johnson, joins the ranks of dividend aristocrats, offering a 3.57% yield, and 2022 sales of $15 billion. 
Via MarketBeat
Topics ETFs
1 Brand-New Dividend Stock Income Investors Won't Want to Miss
The recently spun-off Kenvue looks to be a high-quality dividend stock. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.